TNPSC Thervupettagam

Zosurabalpin antibiotic

January 8 , 2024 316 days 427 0
  • Researchers have identified a new class of antibiotics with the potential to tackle a drug-resistant bacterium, Acinetobacter baumannii.
  • Zosurabalpin was found to be effective against CRAB (carbapenem-resistant Acinetobacter baumannii)-induced pneumonia and sepsis in mouse models.
  • CRAB was at the top of the World Health Organization’s list of antibiotic-resistant “priority pathogens” in 2017.
  • It’s more common in Asia and the Middle East and causes up to 20% of infections in intensive care units worldwide.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories